INVO BIOSCIENCE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8357 USD | -3.72% |
|
-12.95% | -38.10% |
| 05-15 | INVO Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-18 | Top Premarket Decliners | MT |
Chart calendar INVO Bioscience, Inc.
66c56803a46132cb.r1ymZqxbAfjNAfoR0nQZ5_fxHWWvRQj4n6ciHtTrGBw._TTVDNQwVrS1eJRfgEN7tK-zTQjwEU6rx_5PJp27fUjEa8AKnjNGjL9krw~015f790170ed6870e9d6f43180a2055d
Upcoming events on INVO Bioscience, Inc.
Past events on INVO Bioscience, Inc.
| 29/05/2024 | Lytham Partners Spring Investor Conference |
| 15/05/2024 21:15 | Q1 2024 Earnings Release |
| 16/04/2024 21:59 | Q4 2023 Earnings Release |
| 31/01/2024 | Lytham Partners Investor Select Conference |
| 25/12/2023 | Annual General Meeting |
| 19/11/2023 | Q3 2023 Earnings Call |
| 13/11/2023 21:01 | Q3 2023 Earnings Release |
| 31/10/2023 15:30 | Accelerating Biotech Value Creation Meeting |
| 17/10/2023 17:00 | Lytham Partners Fall Investor Conference |
| 13/10/2023 17:00 | Extraordinary Shareholders Meeting |
| 14/08/2023 21:30 | Q2 2023 Earnings Call |
| 14/08/2023 21:05 | Q2 2023 Earnings Release |
| 15/05/2023 21:30 | Q1 2023 Earnings Call |
| 15/05/2023 21:05 | Q1 2023 Earnings Release |
| 17/04/2023 21:30 | Q4 2022 Earnings Call |
| 17/04/2023 21:05 | Q4 2022 Earnings Release |
| 14/11/2022 21:30 | Q3 2022 Earnings Call |
| 14/11/2022 21:05 | Q3 2022 Earnings Release |
| 11/10/2022 | Annual General Meeting |
| 15/08/2022 21:30 | Interim 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 1,04 1,28 -19.08% | 4,16 1,32 214.73% | 0,82 0,80 2.58% | 3,02 3,59 -15.84% |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -5,51 -5,06 -9.08% | -5,22 -8,12 35.72% | -10,6 -10,7 0.23% | -6,77 -8,66 21.85% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -8,35 -6,17 -35.34% | -6,65 -9,20 27.71% | -10,9 -10,9 0.17% | -8,01 -9,08 11.77% |
|
Net income Million USD | Released Forecast Spread | -2,17 | -8,35 -6,17 -35.34% | -6,65 -9,20 27.66% | -10,9 -10,9 0.16% | -8,03 -9,08 11.46% |
|
EPS USD | Released Forecast Spread | -6,40 | -30,4 -19,7 -54.31% | -12,6 -17,5 27.86% | -18,0 -17,0 -5.88% | -5,13 -121 95.77% |
| Announcement Date | 30/03/20 | 30/03/21 | 31/03/22 | 17/04/23 | 16/04/24 |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,16 0,10 66.34% | 0,15 0,33 -55.88% | 0,24 0,23 3.15% | 0,28 0,26 8.02% | 0,35 0,37 -6.94% | 0,32 0,45 -29.8% | 0,97 1,00 -2.22% | 1,38 1,93 -28.33% | 1,58 2,73 -42.18% |
|
EBIT Million USD | Released Forecast Spread | -2,70 -2,56 -5.51% | -2,68 -2,80 4.05% | -2,53 -2,72 7.29% | -2,72 -2,74 0.9% | -2,31 -2,78 16.98% | -2,07 -2,61 20.75% | -0,89 -2,28 61.16% | -1,51 -2,01 24.76% | -0,95 -1,48 36.19% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,77 -3,01 7.83% | -2,80 -2,90 3.42% | -2,55 -2,77 8.09% | -2,76 -2,78 0.68% | -2,55 -2,78 8.18% | -2,24 -2,61 14.17% | -1,25 -2,28 45.37% | -1,97 -2,01 1.66% | -1,59 -1,48 -7.53% |
|
Net income Million USD | Released Forecast Spread | -2,77 -3,01 7.83% | -2,80 -2,90 3.4% | -2,55 -2,77 8.09% | -2,77 -2,78 0.61% | -2,55 -2,78 8.18% | -2,24 -2,61 14.06% | -1,25 -2,28 45.29% | -1,99 -2,01 0.51% | -1,60 -1,48 -7.65% |
|
EPS USD | Released Forecast Spread | -4,60 -5,00 8% | -4,60 -4,80 4.17% | -4,20 -2,40 -75% | -4,60 -3,80 -21.05% | -4,00 -3,20 -25% | -3,06 -4,20 27.14% | -0,70 -19,8 96.46% | -17,4 | |
| Announcement Date | 16/05/22 | 15/08/22 | 14/11/22 | 17/04/23 | 15/05/23 | 14/08/23 | 13/11/23 | 16/04/24 | 15/05/24 |
| 04/07/2024 | MANI, INC.: Q3 2024 Earnings Release |
| 11/07/2024 06:00 | GERRESHEIMER AG: Q2 2024 Earnings Release |
| 12/07/2024 06:00 | ARJO AB: Q2 2024 Earnings Release |
| 12/07/2024 06:30 | XVIVO PERFUSION AB: Q2 2024 Earnings Release |
| 17/07/2024 | ABBOTT LABORATORIES: Q2 2024 Earnings Release (Projected) |
| 17/07/2024 | MEDMIX AG: Q2 2024 Earnings Release |
| 19/07/2024 06:00 | SARTORIUS STEDIM BIOTECH: Q2 2024 Earnings Release |
| 22/07/2024 | NEOGEN CORPORATION: Q4 2024 Earnings Release (Projected) |
| 23/07/2024 | CONMED CORPORATION: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | INTEGRA LIFESCIENCES HOLDINGS CORPORATION: Q2 2024 Earnings Release (Projected) |
Past sector events for INVO Bioscience, Inc.
| Today | SCHOTT PHARMA AG & CO. KGAA: Q2 2024 Earnings Release |
| 18/06/2024 12:00 | PATTERSON COMPANIES, INC.: Q4 2024 Earnings Release |
| 07/06/2024 08:14 | TAIDOC TECHNOLOGY CORPORATION: May 2024 Sales and Revenue Release |
| 05/06/2024 11:00 | MESA LABORATORIES, INC.: Q4 2024 Earnings Release |
| 27/05/2024 21:30 | FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED: Q4 2024 Earnings Release |
| 23/05/2024 11:45 | MEDTRONIC PLC: Q4 2024 Earnings Release |
| 22/05/2024 06:00 | YPSOMED HOLDING AG: Q4 2024 Earnings Release |
| 17/05/2024 09:19 | POLY MEDICURE LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 07:00 | CONVATEC GROUP PLC: Q1 2024 Sales and Revenue Release - Trading Update |
| 15/05/2024 03:00 | HOYA CORPORATION: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- INVO Stock
- Calendar INVO Bioscience, Inc.
